{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:32:58Z","timestamp":1791973978929,"version":"4.4.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.nmd.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:45:27Z","timestamp":1696625127000},"page":"824-834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Emerging and established biomarkers of oculopharyngeal muscular dystrophy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-1710","authenticated-orcid":false,"given":"Ian C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoni","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre R.","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos L.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Melkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woulfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0187-2199","authenticated-orcid":false,"given":"Jodi","family":"Warman-Chardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.09.010_bib0001","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","article-title":"Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy","volume":"18","author":"Brais","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0002","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nmd.2006.11.009","article-title":"Siblings with recessive oculopharyngeal muscular dystrophy","volume":"17","author":"Hebbar","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0003","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mus.20726","article-title":"Variability of the recessive oculopharyngeal muscular dystrophy phenotype","volume":"35","author":"Semmler","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0004","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12017-014-8327-5","article-title":"Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population","volume":"16","author":"Shan","year":"2014","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.nmd.2023.09.010_bib0005","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM196212202672501","article-title":"Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids","volume":"267","author":"Victor","year":"1962","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.nmd.2023.09.010_bib0006","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0960-8966(97)00086-2","article-title":"Using the full power of linkage analysis in 11 French Canadian families to fine map the oculopharyngeal muscular dystrophy gene","volume":"7","author":"Brais","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000003554","article-title":"Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy","volume":"88","author":"Richard","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000077070","article-title":"Mitochondrial abnormalities in genetically assessed oculopharyngeal muscular dystrophy","volume":"51","author":"Gambelli","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp.2006.112250","article-title":"Multiple mitochondrial DNA deletions in monozygotic twins with OPMD","volume":"79","author":"Muqit","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.09.010_bib0010","doi-asserted-by":"crossref","first-page":"NP260","DOI":"10.1093\/asj\/sjaa429","article-title":"The function-preserving frontalis orbicularis oculi muscle flap for the correction of severe blepharoptosis with poor levator function","volume":"41","author":"Huang","year":"2021","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.nmd.2023.09.010_bib0011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/IOP.0000000000002118","article-title":"Oculopharyngeal muscular dystrophy ptosis, Mueller's muscle involvement, and a review of management over 34 years","volume":"38","author":"Jordan","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.nmd.2023.09.010_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/01676830.2022.2122514","article-title":"A review of surgical management of progressive myogenic ptosis","volume":"42","author":"Park","year":"2023","journal-title":"Orbit"},{"key":"10.1016\/j.nmd.2023.09.010_bib0013","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00455-011-9356-y","article-title":"Cricopharyngeal dilatation for the long-term treatment of dysphagia in oculopharyngeal muscular dystrophy","volume":"27","author":"Manjaly","year":"2012","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0014","doi-asserted-by":"crossref","first-page":"843","DOI":"10.17235\/reed.2016.4266\/2016","article-title":"Utility of surgical myotomy in the dysphagia due to oculopharyngeal dystrophy","volume":"108","author":"Acosta Merida","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.nmd.2023.09.010_bib0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mus.24123","article-title":"Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy","volume":"49","author":"Youssof","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071375","article-title":"Recent progress in oculopharyngeal muscular dystrophy","volume":"10","author":"Yamashita","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2023.09.010_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mus.26888","article-title":"A study of impairments in oculopharyngeal muscular dystrophy","volume":"62","author":"Brisson","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0018","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nmd.2013.03.001","article-title":"191st ENMC international workshop: recent advances in oculopharyngeal muscular dystrophy research: from bench to bedside 8\u201310 June 2012, Naarden, The Netherlands","volume":"23","author":"Raz","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0019","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1212\/WNL.55.9.1267","article-title":"Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene","volume":"55","author":"Blumen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0020","first-page":"376","article-title":"Haplotype analysis of oculopharyngeal muscular dystrophy (OPMD) locus in yakutia","volume":"52","author":"Marusin","year":"2016","journal-title":"genetika"},{"issue":"Suppl 1","key":"10.1016\/j.nmd.2023.09.010_bib0021","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0960-8966(97)00074-6","article-title":"Andre Barbeau and the oculopharyngeal muscular dystrophy in French Canada and North America","volume":"7","author":"Bouchard","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0022","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.286.19.2437","article-title":"Oculopharyngeal muscular dystrophy in Hispanic New Mexicans","volume":"286","author":"Becher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.nmd.2023.09.010_bib0023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0960-8966(93)90119-5","article-title":"Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews","volume":"3","author":"Blumen","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0024","first-page":"52","article-title":"The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia)","volume":"108","author":"Maksimova","year":"2008","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.nmd.2023.09.010_bib0025","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/ene.15252","article-title":"Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands","volume":"29","author":"Alonso-Perez","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0026","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00439-004-1235-2","article-title":"Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism","volume":"116","author":"Robinson","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0027","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1074\/jbc.RA118.007287","article-title":"Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle","volume":"294","author":"Banerjee","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2023.09.010_bib0028","doi-asserted-by":"crossref","first-page":"22803","DOI":"10.1074\/jbc.M109.018226","article-title":"Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor","volume":"284","author":"Kuhn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2023.09.010_bib0029","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/emboj\/cdg347","article-title":"Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA","volume":"22","author":"Kerwitz","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.nmd.2023.09.010_bib0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(91)90119-J","article-title":"A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation","volume":"66","author":"Wahle","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2023.09.010_bib0031","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1111\/febs.12294","article-title":"PABPN1: molecular function and muscle disease","volume":"280","author":"Banerjee","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.nmd.2023.09.010_bib0032","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/hmg\/ddp569","article-title":"Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis","volume":"19","author":"Apponi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0033","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0092-8674(01)00475-5","article-title":"Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20","volume":"106","author":"Ishigaki","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2023.09.010_bib0034","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/oxfordjournals.hmg.a018924","article-title":"Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA","volume":"9","author":"Calado","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0","article-title":"Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy","volume":"23","author":"Uyama","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0036","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nbd.2004.10.019","article-title":"PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions","volume":"18","author":"Corbeil-Girard","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2023.09.010_bib0037","series-title":"Neuromuscular disorders","article-title":"Neuromuscular disorders","author":"Dionne","year":"2011"},{"key":"10.1016\/j.nmd.2023.09.010_bib0038","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1136\/jmg.2005.037598","article-title":"Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation","volume":"43","author":"Robinson","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12883-021-02300-x","article-title":"A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35 G >C; p.Gly12Ala point mutation","volume":"21","author":"Nishii","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0040","unstructured":"Urtizberea J.A. Oculopharyngeal muscular dystrophy. 2004 February 2004 [cited 2022 April 13]; Available from: https:\/\/www.orpha.net\/data\/patho\/GB\/uk-OPMD.pdf."},{"key":"10.1016\/j.nmd.2023.09.010_bib0041","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm1242","article-title":"Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice","volume":"11","author":"Davies","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2023.09.010_bib0042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/emmm.201000109","article-title":"Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy","volume":"3","author":"Barbezier","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.nmd.2023.09.010_bib0043","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/hmg\/ddz007","article-title":"Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy","volume":"28","author":"Malerba","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddi422","article-title":"Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy","volume":"15","author":"Davies","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"16 Supplement","key":"10.1016\/j.nmd.2023.09.010_bib0045","article-title":"Intravenous trehalose improves dysphagia and muscle function in oculopharyngeal muscular dystrophy (OPMD): preliminary results of 24 weeks open label phase 2 trial (S28.004)","volume":"86","author":"Argov","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtn.2021.02.017","article-title":"BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy","volume":"24","author":"Strings-Ufombah","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.nmd.2023.09.010_bib0047","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1038\/ncomms14848","article-title":"PABPN1 gene therapy for oculopharyngeal muscular dystrophy","volume":"8","author":"Malerba","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2023.09.010_bib0048","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/mt.2013.155","article-title":"Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I\/IIa clinical study","volume":"22","author":"Perie","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2023.09.010_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-023-00775-6","article-title":"Therapeutic approaches for Duchenne muscular dystrophy","author":"Roberts","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nmd.2023.09.010_bib0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jcsm.12438","article-title":"Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)","volume":"10","author":"Harish","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.nmd.2023.09.010_bib0051","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphys.2020.00184","article-title":"Inhibition of myostatin reduces collagen deposition in a mouse model of oculopharyngeal muscular dystrophy (OPMD) with established disease","volume":"11","author":"Harish","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0052","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1152\/japplphysiol.00126.2006","article-title":"Contractile properties of EDL and soleus muscles of myostatin-deficient mice","volume":"101","author":"Mendias","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0053","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0054","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nmd.2016.11.013","article-title":"Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids","volume":"27","author":"Goemans","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nmd.2013.05.006","article-title":"Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids","volume":"23","author":"Goemans","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0056","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","article-title":"Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes","volume":"52","author":"Cortese","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0057","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/biom11081246","article-title":"Circulating biomarkers in neuromuscular disorders: what is known, what is new","volume":"11","author":"Barp","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.nmd.2023.09.010_bib0058","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet Med"},{"issue":"Suppl 1","key":"10.1016\/j.nmd.2023.09.010_bib0059","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s40264-014-0182-7","article-title":"Evolution of the food and drug administration approach to liver safety assessment for new drugs: current status and challenges","volume":"37","author":"Senior","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.nmd.2023.09.010_bib0060","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0192623320985045","article-title":"A Review of specific biomarkers of chronic renal injury and their potential application in nonclinical safety assessment studies","volume":"49","author":"Obert","year":"2021","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0061","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11910-015-0584-7","article-title":"Axons to exons: the molecular diagnosis of rare neurological diseases by next-generation sequencing","volume":"15","author":"Warman Chardon","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2023.09.010_bib0062","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00415-008-0769-y","article-title":"Unique PABPN1 gene mutation in a large Bulgarian family with OPMD","volume":"255","author":"Mihaylova","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0063","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archneur.56.11.1378","article-title":"Mutation analysis of oculopharyngeal muscular dystrophy in Hispanic American families","volume":"56","author":"Grewal","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0064","first-page":"291","article-title":"Oculopharyngeal muscular dystrophy as a rare cause of dysphagia","volume":"28","author":"Werling","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0065","series-title":"ASHG Annual Meeting","article-title":"Autosomal recessive oculopharyngeal muscular dystrophy - an underrecognized syndrome?","author":"Spriggs","year":"2004"},{"key":"10.1016\/j.nmd.2023.09.010_bib0066","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O","article-title":"Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease","volume":"46","author":"Blumen","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0067","first-page":"239","article-title":"Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene","volume":"19","author":"Pou Serradell","year":"2004","journal-title":"Neurologia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0068","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ene.14131","article-title":"Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy","volume":"27","author":"Galimberti","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0069","first-page":"98","article-title":"Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: case report and review of literature","volume":"16","author":"Aryani","year":"2017","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0070","unstructured":"Trollet C., Boulinguiez A., Roth F., Stojkovic T., Butler-Browne G., Evangelista T., et\u00a0al. Oculopharyngeal muscular dystrophy. In: Adam M P, et\u00a0al. editor GeneReviews((R)). Seattle (WA), 1993."},{"key":"10.1016\/j.nmd.2023.09.010_bib0071","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure for neuromuscular diseases. Construction and validation study","volume":"15","author":"Berard","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0072","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1212\/WNL.0000000000012640","article-title":"Longitudinal assessment of strength, functional capacity, oropharyngeal function, and quality of life in oculopharyngeal muscular dystrophy","volume":"97","author":"Kroon","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0073","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/thx.39.11.818","article-title":"Effect of encouragement on walking test performance","volume":"39","author":"Guyatt","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2023.09.010_bib0074","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/13682820701234444","article-title":"Reliability of speech diadochokinetic test measurement","volume":"43","author":"Gadesmann","year":"2008","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.11124\/jbisrir-2014-1503","article-title":"Muscle strength in adults with spinal cord injury: a systematic review of manual muscle testing, isokinetic and hand held dynamometry clinimetrics","volume":"12","author":"Peek","year":"2014","journal-title":"JBI Database System Rev Implement Rep"},{"key":"10.1016\/j.nmd.2023.09.010_bib0076","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pmrj.2010.10.025","article-title":"Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review","volume":"3","author":"Stark","year":"2011","journal-title":"PM R"},{"key":"10.1016\/j.nmd.2023.09.010_bib0077","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.sc.3100646","article-title":"Comparison of three methods to assess muscular strength in individuals with spinal cord injury","volume":"36","author":"Noreau","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0078","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sc.1996.98","article-title":"Strength post-spinal cord injury: myometer vs manual muscle test","volume":"34","author":"Herbison","year":"1996","journal-title":"Spinal Cord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0079","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/WNL.0000000000001336","article-title":"Measuring quality of life in muscular dystrophy","volume":"84","author":"Bann","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mus.26712","article-title":"Patient-reported disease burden in oculopharyngeal muscular dystrophy","volume":"60","author":"Kurtz","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0081","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.nmd.2017.09.010","article-title":"Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy","volume":"27","author":"van der Sluijs","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0082","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0016-5085(00)70137-5","article-title":"Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia","volume":"118","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0083","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s004550010013","article-title":"The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling","volume":"15","author":"McHorney","year":"2000","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0084","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s004550010012","article-title":"The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development","volume":"15","author":"McHorney","year":"2000","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00455-001-0109-1","article-title":"The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity","volume":"17","author":"McHorney","year":"2002","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0086","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11136-021-02915-0","article-title":"Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population","volume":"31","author":"Cote","year":"2022","journal-title":"Qual Life Res"},{"key":"10.1016\/j.nmd.2023.09.010_bib0087","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JND-150118","article-title":"Intranuclear aggregates precede clinical onset in oculopharyngeal muscular dystrophy","volume":"3","author":"van der Sluijs","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.09.010_bib0088","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nmd.2016.05.001","article-title":"Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene","volume":"26","author":"Matsubara","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0089","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/hmg\/ddh101","article-title":"Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus","volume":"13","author":"Berciano","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/NEN.0b013e3182854c07","article-title":"Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients","volume":"72","author":"Gidaro","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0091","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.nbd.2004.09.021","article-title":"Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice","volume":"18","author":"Dion","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2023.09.010_bib0092","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4161\/nucl.2.3.15736","article-title":"Reversible aggregation of PABPN1 pre-inclusion structures","volume":"2","author":"Raz","year":"2011","journal-title":"Nucleus"},{"key":"10.1016\/j.nmd.2023.09.010_bib0093","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11910-009-0012-y","article-title":"Oculopharyngeal muscular dystrophy: a polyalanine myopathy","volume":"9","author":"Brais","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2023.09.010_bib0094","doi-asserted-by":"crossref","first-page":"412","DOI":"10.18632\/aging.100567","article-title":"A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging","volume":"5","author":"Anvar","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.nmd.2023.09.010_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00692226","article-title":"Nuclear inclusions in oculopharyngeal dystrophy","volume":"49","author":"Tome","year":"1980","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0096","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2044-5040-3-23","article-title":"Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle","volume":"3","author":"Apponi","year":"2013","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2023.09.010_bib0097","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nmd.2019.08.011","article-title":"MYO-MRI diagnostic protocols in genetic myopathies","volume":"29","author":"Warman Chardon","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0098","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.nmd.2020.08.360","volume":"30","author":"Warman-Chardon","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0099","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00415-016-8350-6","article-title":"Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review","volume":"264","author":"Leung","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp-2018-319578","article-title":"Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy","volume":"90","author":"Alonso-Jimenez","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.09.010_bib0101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2022.09.010","article-title":"Quantitative vs qualitative muscle MRI: imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD)","volume":"33","author":"Melkus","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jmri.22431","article-title":"Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods","volume":"33","author":"Gloor","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nmd.2023.09.010_bib0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-160145","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials","volume":"3","author":"Carlier","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.09.010_bib0104","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s00415-011-6393-2","article-title":"Quantitative MRI can detect subclinical disease progression in muscular dystrophy","volume":"259","author":"Fischmann","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4314\/ahs.v17i1.17","article-title":"Effect of posture on swallowing","volume":"17","author":"Alghadir","year":"2017","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.nmd.2023.09.010_bib0106","doi-asserted-by":"crossref","DOI":"10.1136\/pn-2022-003422","article-title":"Weakness in the intensive care unit","author":"Walters","year":"2022","journal-title":"Pract Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0107","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.21015","article-title":"Muscle ultrasound in neuromuscular disorders","volume":"37","author":"Pillen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0108","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mus.27258","article-title":"Quantitative muscle echointensity: a practical approach using ultrasound to evaluate children with suspected neuromuscular disorders","volume":"64","author":"Zaidman","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2023.09.010_bib0109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41983-018-0039-6","article-title":"The role of muscle ultrasound in helping the clinical diagnosis of muscle diseases","volume":"54","author":"Helmy","year":"2018","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"10.1016\/j.nmd.2023.09.010_bib0110","article-title":"Technical challenges of imaging & image-guided interventions in obese patients","volume":"91","author":"Uppot","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0111","first-page":"S153","article-title":"EP.339 Longitudinal assessment of muscle ultrasound in oculopharyngeal muscular dystrophy","volume":"31","author":"Kroon","year":"2021","journal-title":"Imaging"},{"key":"10.1016\/j.nmd.2023.09.010_bib0112","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00455-018-9904-9","article-title":"A preliminary videofluoroscopic investigation of swallowing physiology and function in individuals with oculopharyngeal muscular dystrophy (OPMD)","volume":"33","author":"Waito","year":"2018","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00455-009-9258-4","article-title":"Fluoroscopic surrogate for pharyngeal strength: the pharyngeal constriction ratio (PCR)","volume":"26","author":"Leonard","year":"2011","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2023.09.010_bib0114","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jnnp.2005.062521","article-title":"Ptosis aggravates dysphagia in oculopharyngeal muscular dystrophy","volume":"77","author":"de Swart","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2023.09.010_bib0115","doi-asserted-by":"crossref","first-page":"e13251","DOI":"10.1111\/nmo.13251","article-title":"Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy","volume":"30","author":"Tabor","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.nmd.2023.09.010_bib0116","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JND-200511","article-title":"Swallowing, chewing and speaking: frequently impaired in oculopharyngeal muscular dystrophy","volume":"7","author":"Kroon","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.09.010_bib0117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.30283","article-title":"Dynamic imaging grade of swallowing toxicity (DIGEST): scale development and validation","volume":"123","author":"Hutcheson","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.nmd.2023.09.010_bib0118","doi-asserted-by":"crossref","DOI":"10.21926\/obm.geriatr.2101153","article-title":"Which physiological swallowing parameters change with healthy aging?","volume":"5","author":"Mancopes","year":"2021","journal-title":"OBM Geriat"},{"key":"10.1016\/j.nmd.2023.09.010_bib0119","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700071","article-title":"Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy","volume":"12","author":"Carr","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.nmd.2023.09.010_bib0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1474-4422(20)30028-4","article-title":"Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development","volume":"19","author":"Thompson","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2044-5040-1-15","article-title":"Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients","volume":"1","author":"Anvar","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2023.09.010_bib0122","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ajpath.2011.06.044","article-title":"Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein","volume":"179","author":"Raz","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0123","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.nmd.2023.09.010_bib0124","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.3390\/ijms21176059","article-title":"Age-associated salivary MicroRNA biomarkers for oculopharyngeal muscular dystrophy","volume":"21","author":"Raz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2023.09.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167969","article-title":"Stability of circulating blood-based MicroRNAs - pre-analytic methodological considerations","volume":"12","author":"Glinge","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2023.09.010_bib0126","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700073","article-title":"Intersection of proteomics and genomics to \"solve the unsolved\" in rare disorders such as neurodegenerative and neuromuscular diseases","volume":"12","author":"Roos","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.nmd.2023.09.010_bib0127","article-title":"Proteomic Investigation of the Molecular Pathophysiology of Oculo-Pharyngeal Muscular Dystrophy (OPMD), in Myology 2008","author":"Bouazza","year":"2008"},{"key":"10.1016\/j.nmd.2023.09.010_bib0128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.nmd.2023.09.010_bib0129","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2023.09.010_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.nmd.2023.09.010_bib0131","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s00415-011-6374-5","article-title":"Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy","volume":"259","author":"Tondo","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0132","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/pr.2015.237","article-title":"Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin","volume":"79","author":"Sethi","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.nmd.2023.09.010_bib0133","article-title":"Advances in aptamer-based biomarker discovery","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0134","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.steroids.2018.10.008","article-title":"Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis","volume":"140","author":"Conklin","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.nmd.2023.09.010_bib0135","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddaa132","article-title":"Serum biomarkers associated with baseline clinical severity in young steroid-naive Duchenne muscular dystrophy boys","volume":"29","author":"Dang","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0136","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028498","article-title":"The future of the cytokine discipline","volume":"10","author":"Oppenheim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0137","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1093\/hmg\/ddw259","article-title":"Cytokine genes as potential biomarkers for muscle weakness in OPMD","volume":"25","author":"Riaz","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0138","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nmd.2008.12.003","article-title":"Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot study","volume":"19","author":"Bouazza","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.010_bib0139","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40798-020-0238-4","article-title":"Metabolite concentration changes in humans after a bout of exercise: a systematic review of exercise metabolomics studies","volume":"6","author":"Schranner","year":"2020","journal-title":"Sports Med Open"},{"key":"10.1016\/j.nmd.2023.09.010_bib0140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/nu10081063","article-title":"Nutritional metabolomics: postprandial response of meals relating to vegan, lacto-ovo vegetarian, and omnivore diets","volume":"10","author":"Radjursoga","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.nmd.2023.09.010_bib0141","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/metabo9060108","article-title":"Translational metabolomics: current challenges and future opportunities","volume":"9","author":"Pinu","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.nmd.2023.09.010_bib0142","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/metabo13060769","article-title":"Novel metabolomic approach for identifying pathology-specific biomarkers in rare diseases: a case study in oculopharyngeal muscular dystrophy (OPMD)","volume":"13","author":"Harish","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.nmd.2023.09.010_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102430","article-title":"DNA methylation: precise modulation of chromatin structure and dynamics","volume":"75","author":"Li","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.nmd.2023.09.010_bib0144","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.isci.2019.01.024","article-title":"Deacetylation inhibition reverses PABPN1-dependent muscle wasting","volume":"12","author":"Olie","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.nmd.2023.09.010_bib0145","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/hmg\/ddn109","article-title":"Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1","volume":"17","author":"Catoire","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0146","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1212\/WNL.0000000000005942","article-title":"Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy","volume":"91","author":"Abu-Baker","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2023.09.010_bib0147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005092","article-title":"Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis","volume":"11","author":"Chartier","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0148","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/hmg\/ddq098","article-title":"Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres","volume":"19","author":"Trollet","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0149","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/hmg\/ddx206","article-title":"Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology","volume":"26","author":"Vest","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.09.010_bib0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.1994.2732","article-title":"Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles","volume":"205","author":"Lezza","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2023.09.010_bib0151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2015.08.024","article-title":"Differentiating between monozygotic twins through next-generation mitochondrial genome sequencing","volume":"490","author":"Wang","year":"2015","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nmd.2023.09.010_bib0152","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-5793(97)01374-4","article-title":"Mitochondrial DNA deletions in oculopharyngeal muscular dystrophy","volume":"418","author":"Lezza","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nmd.2023.09.010_bib0153","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fgene.2019.01203","article-title":"The impact of pathway database choice on statistical enrichment analysis and predictive modeling","volume":"10","author":"Mubeen","year":"2019","journal-title":"Front Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T18:41:27Z","timestamp":1717526487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623007368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":153,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0960896623007368"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.09.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging and established biomarkers of oculopharyngeal muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}